Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Cross-vendor view of every Certificate of Analysis for Vesugen: purity distribution, test coverage gaps, recent batches. Sourced back to the original COAs.
Each dot is one COA. Color = vendor. The dashed line is a recency-weighted rolling mean (6-month half-life) — it tells you whether testing is trending up or down across the corpus, independent of which vendors happen to have published most recently. Tightly clustered points across many vendors = either real consistency or rubber-stamping; check the individual labs.
| Vendor | COAs | Avg purity | MS | Endotoxin | Sterility | Metals | Latest |
|---|---|---|---|---|---|---|---|
| BioLongevity Labs | 5 | 99.72% |
| Vendor | Lab | Lot | Purity | Tested | |
|---|---|---|---|---|---|
| BioLongevity Labs | MDx BioAnalytical Laboratory | — | — | — | View |
| BioLongevity Labs | MDx BioAnalytical Laboratory | — | 99.80% | — | View |
| Kimera Chems | Freedom Diagnostics | KC-VSG-PNK1 | 99.63% | 2026-03-13 | View |
| Peptidology | Vanguard Laboratory | 1671 | 99.53% | 2026-02-13 |
| — |
| 2026-02-13 |
| Kimera Chems | 1 | 99.63% | — | 2026-03-13 |
| Peptidology | 1 | 99.53% | — | 2026-02-13 |
| Verified Peptides | 1 | 99.27% | — | — | 2025-11-18 |
| View |
| BioLongevity Labs | BioRegen | 46-3-46057 | 99.76% | 2026-02-13 | View |
| Verified Peptides | Janoshik Analytical | 12-25-0220B | 99.27% | 2025-11-18 | View |
| BioLongevity Labs | BioRegen | 46-3-45954 | 99.84% | 2025-11-12 | View |
| BioLongevity Labs | MDx BioAnalytical Laboratory | — | 99.50% | 2025-10-30 | View |